Treatment of a septic patient with acquired haemophilia;Traitement d'une hémophilie acquise chez un patient septique

Revue de Medecine Interne

Volumn 24, Issue 10, 2003, Pages 692-695

  Laporte, F ^a   Cestac, P ^b   Favre, V ^a   DeRoch, X Seree ^a   Khatibi, S ^a   Bonnet, E ^a   Massip, P ^a   Sie, P ^a   Bellon, B ^a  

^a CHU PURPAN   (France)

^b Serv Univ Psychiat l'Enfant l'A   (France)

Author keywords

Acquired haemophilia A; Prothrombinic complex concentrates; Septicemia

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 8; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; TEICOPLANIN; VANCOMYCIN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; AUTOIMMUNITY; BLEEDING TENDENCY; CASE REPORT; HEMATOMA; HEMOPHILIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PARTIAL THROMBOPLASTIN TIME; RHEUMATOID ARTHRITIS; SEPSIS; SEPTICEMIA;

EID: 0141989898     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(03)00253-4     Document Type: Article

References (14)

1. Lottenberg R, Kentro TB, Kitchen CS. A natural history study of 16 patients with factor inhibitors receiving little or no therapy. Arch Intern Med 1987;147:1077-81.
2. Green D, Lechner K. A survey of 215 non haemophilic patients with Inhibitors to factor VIII. Thromb Haemostasis 1981;45:200-3.
3. Bossi P, Cabane J, Ninet J, Dhote R, Hanslik T, Chosidow O, et al. Acquired haemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998;105:400-8.
4. Saxena R, Mishra DK, Kashyap R, Choudhry VP, Mahapatra M, Bhargava M. Acquired haemophilia: a study of 10 cases. Haemophilia 2000;6:78-83.
5. Lian ECY, Larcada AF, Chiu AYZ. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann intern Med 1989;110:774-8.
6. Levesque H, Borg JY, Bossi P, Goudemand J, Guillet B, Cabane J. Hémophilie acquise: diagnostic et prise en charge thérapeutique. Rev Med Interne 2001;22:854-66.
7. Lafferty TE, Smith JB, Schuster SJ, Dehoratius RJ. Treatment of acquired factor VIII inhibitor using intravenous immunoglobulin in two patients with systemic lupus erythematosus. Arthritis Rheum 1997;40:775-8.
8. Schwartz RS, Gabriel DA, Aledort L, Green D, Kessler CM. A prospective study of treatment of acquired (auto-immune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995; 86:797-804.
9. Crenier L, Ducohu J, Des Grottes JM, Cerny J, Delaunoit C, Capel P. Low response to high-dose intravenous Immunoglobulin in the treatment of acquired factor VIII inhibitor. Br J Haematol 1996;95:750-3.
10. Shaffer LG, Phillips MD. Successful treatment of acquired haemophilia with oral immunosuppressive therapy. Ann Intern Med 1997; 127:206-9.
11. Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired factor VIII:C inhibitors. Br J Haematol 1981;48:635-42.
12. Hay CRM. Acquired haemophilia. Clin Haematol 1998;11:287-303.
13. Gallistl S, Cvirn G, Leschnik B, Muntean W. Respective roles of factors II, VII, IX, and X in the procoagulant activity of Feiba®. Blood Coagul Fibrinolysis 2002 Oct;13(7):653-5.
14. Turecek PL, Varadi K, Gritsch H, Auer W, Pichler L, Eder G, Schwarz HP. Factor Xa and prothrombin: mechanism of action of Feiba®. Vox Sang 1999;77(Suppl 1):72-9.